NYSE:OGN

Organon & Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy OGN

*Your capital is at risk

$13.45

+0.0500 (+0.373%)

At Close: Jun 23, 2026

Organon & Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 67.98. In total, the insiders bought 2.6B and sold 105.4M OGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	67.98
● Buy	2.6B shares
● Sell	105.4M shares
73% Buy Activity Strong Negative Correlation
Sell Signal Low Confidence May 06, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 67.98. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 12, 2026 Buy	Phantom Stock A-Award	Ozuah Philip Director	Director	17 857 Value: $240.0K
Jun 12, 2026 Buy	Phantom Stock A-Award	Leone Deborah R Director	Director	17 857 Value: $240.0K
Jun 12, 2026 Buy	Phantom Stock A-Award	Gayle Helene D Director	Director	17 857 Value: $240.0K
Jun 12, 2026 Buy	Phantom Stock A-Award	Essner Robert Director	Director	17 857 Value: $240.0K
Jun 12, 2026 Buy	Phantom Stock A-Award	Ezekowitz Alan Director	Director	17 857 Value: $240.0K
Jun 12, 2026 Buy	Phantom Stock A-Award	Lazarus Rochelle B Director	Director	17 857 Value: $240.0K
Jun 12, 2026 Buy	Phantom Stock A-Award	Patton Cynthia M Director	Director	17 857 Value: $240.0K
Jun 12, 2026 Buy	Phantom Stock A-Award	Sequeira Ramona Director	Director	17 857 Value: $240.0K
Jun 12, 2026 Buy	Phantom Stock A-Award	Sharp Shalini Director	Director	17 857 Value: $240.0K
May 06, 2026 Buy	Common Stock J-Other	Holzbaur Lynette SVP And Corporate Controller	Officer	46 Value: $616
May 06, 2026 Buy	Common Stock P-Purchase	Holzbaur Lynette SVP And Corporate Controller	Officer	26 448 Value: $353.1K
May 06, 2026 Sell	Common Stock S-Sale	Holzbaur Lynette SVP And Corporate Controller	Officer	26 448 Value: $353.1K
Mar 31, 2026 Buy	Common Stock M-Exempt	Walsh Matthew M Chief Financial Officer	C-Suite Officer	12 047 Value: $72.2K
Mar 31, 2026 Sell	Common Stock F-InKind	Walsh Matthew M Chief Financial Officer	C-Suite Officer	7 380 Value: $42.1K
Mar 31, 2026 Buy	Common Stock M-Exempt	Walsh Matthew M Chief Financial Officer	C-Suite Officer	21 546 Value: $129.1K
Mar 31, 2026 Sell	Common Stock F-InKind	Stahler Rachel A Chief Information Officer	Officer	2 246 Value: $12.8K
Mar 31, 2026 Buy	Common Stock M-Exempt	Stahler Rachel A Chief Information Officer	Officer	6 555 Value: $39.3K
Mar 31, 2026 Buy	Common Stock M-Exempt	Karp Daniel Executive Vp, Corp. Dev.	Officer	6 715 Value: $40.2K
Mar 31, 2026 Buy	Restricted Stock Units A-Award	Karp Daniel Executive Vp, Corp. Dev.	Officer	100 166 Value: $600.0K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Arjona Ferreira Juan Camilo Head Of R&d & Cmo	Officer	13 431 Value: $80.5K
Mar 31, 2026 Sell	Common Stock F-InKind	Arjona Ferreira Juan Camilo Head Of R&d & Cmo	Officer	4 820 Value: $27.5K
Mar 31, 2026 Buy	Common Stock M-Exempt	Arjona Ferreira Juan Camilo Head Of R&d & Cmo	Officer	13 431 Value: $80.5K
Mar 31, 2026 Buy	Restricted Stock Units A-Award	Arjona Ferreira Juan Camilo Head Of R&d & Cmo	Officer	200 333 Value: $1.20M
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Drinane Juliana Papa Interim Head Of Mfg & Supply	Officer	6 378 Value: $38.2K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Drinane Juliana Papa Interim Head Of Mfg & Supply	Officer	10 073 Value: $60.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ORGANON & CO.

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology pr...

Read Full Profile Here